Angiotensin converting enzyme inhibitors or angiotensin in diabetic nephropathy
Journal Title: Przewodnik Lekarza - Year 2005, Vol 81, Issue 9
Abstract
Diabetic nephropathy occurs is the single leading cause of end-stage renal disease. Intensive diabetes management has been shown in large prospective randomized studies to delay the onset of microalbuminuria and the progression of micro- to macroalbuminuria. In the treatment of both micro- and macroalbuminuria, either angiotensin converting enzyme inhibitors or angiotensin II antagonist should be used except during pregnancy.
Authors and Affiliations
Marcin Grabowski, Krzysztof Filipiak, Grzegorz Opolski
Keywords
Related Articles
- EP ID EP159794
- DOI -
- Views 88
- Downloads 0
ASCOT Study confirms the benefit of new classes of hipotensive drugs
Cervical lymphadenopathy; taxoplasmosis in the course of Hodgkin\'s diseases - case report and review of literature
In most cases the process of reaching the diagnosis of the patient with cervical lyphadenopathy is not so difficult. Preliminary diagnosis based on detailed anamnesis and accurate physical examination may turn out, that...
Mikogram
Embolic and thrombotic disorders in the clinical aspects of nervous system vessel disease - prophylaxis and therapy
Embolic and thrombotic disorders in the clinical aspects of nervous system vessel disease – prophylaxis and therapy. Ischemic cerebral stroke is a serious disease nowadays. The thrombotic etiology is one of its patomech...
Acute limb ischemia
Acute limb ischemia is defined as sudden decrease or worsening in limb perfusion causing a potential threat to extremity viability. Etiology of acute limb ischemia is secondary to emboli, arterial thrombosis, trauma, aor...